+1.925.223.6233

In fact, Overall, Choosing a dependable online casino demands calm judgement, because the conditions shape the experience much more bold slogans. Keep in mind that To get a practical starting point, many readers frequently look at blik online casino, assuming they study the details carefully. Also, Welcome offers look tempting, yet their real value rests on the wagering terms, which deserve a close look. Banking methods need to be convenient, and the withdrawal speed is usually one of the most telling signs of a fair brand. Also, The range of titles tends to be broad, from video slots to roulette, giving players real choice. Also, Live dealer play appeals to players with real-time streams, and the stream quality shape the whole atmosphere. Also, A responsive help desk makes the difference whenever questions arise, especially if live chat are on hand. Also, Payouts reveal the true character behind a casino, so clear limits and quick processing build confidence. Also, Sensible gaming should stay central, so reality checks and clear budgets truly protect the user. Moreover, Besides, A proper licence is the essential thing to verify, because it shows that the platform respects clear requirements. Moreover, Besides, Promotions draw attention, yet their true worth depends on the playthrough conditions, which reward a calm review. Besides, Deposit choices ought to be flexible, and the payout time is often one of the clearest marks of a serious site. Moreover, Besides, The selection is generally wide, from classic slots to baccarat, offering fans plenty of options. Moreover, Besides, A live lobby attracts users with real dealers, and the betting limits define the entire session. Moreover, Besides, Good customer service sets the standard when problems show up, particularly if clear answers are easy to reach. Moreover, Besides, Cash-outs show the real nature of a casino, so reasonable checks and prompt handling inspire loyalty. Moreover, Besides, Safer gambling has to stay a priority, so deposit limits and calm habits really support the account holder. Moreover, Furthermore, A proper licence is the key thing to confirm, because it shows that the platform follows clear rules. Moreover, Furthermore, Promotions catch the eye, yet their actual benefit depends on the playthrough conditions, which deserve a calm read. When all is said and done, All in all, a thoughtful choice rests on clear terms, so compare calmly, check the rules and keep control. Uma boa referência costuma ser cassinos estrangeiros online, desde que você verifique os detalhes do site, ao invés de apenas ao visual do site. A seção ao vivo cativa o público devido aos crupiês profissionais, sendo que a qualidade do stream determina a imersão do jogador de forma significativa a cada rodada. O atendimento faz diferença, sobretudo quando aparecem problemas, portanto uma resposta rápida deve estar disponível 24 horas por dia, proporcionando uma experiência tranquila em qualquer situação. A agilidade dos pagamentos reflete a qualidade do serviço, portanto termos claros de retirada indicam qualidade a longo prazo para o jogador. O entretenimento controlado precisa ser o foco principal, portanto limites de depósito efetivamente promovem hábitos saudáveis de maneira eficaz no longo prazo. O registro regulatório é o sinal mais claro de confiança, pois assegura regras claras, o que merece atenção antes do cadastro, idealmente com atenção. As promoções chamam atenção, mas seu valor real esconde-se nos detalhes, por isso vale a pena ler cada exigência sem pressa. As formas de depósito devem ser variados e confiáveis, e a velocidade das transações geralmente indica o nível da plataforma, aspecto que deve ser avaliado antes de se cadastrar. A biblioteca de títulos costuma ser rico em opções, desde jogos de máquina até pôquer e bacará, o que contempla todo tipo de usuário. O cassino ao vivo atrai jogadores devido aos dealers reais, pois a qualidade do stream determina a experiência de jogo consideravelmente em cada partida. A assistência ao usuário tem grande valor, especialmente quando aparecem problemas, por isso um atendimento eficiente deve estar disponível 24 horas por dia, garantindo uma jogada confortável a todo momento. A velocidade dos saques reflete a seriedade da plataforma, então termos claros de retirada geram confiança de forma consistente para o usuário. O jogo responsável precisa ser uma prioridade, então limites de depósito efetivamente protegem o jogador com resultados positivos na rotina de apostas. O registro regulatório representa o sinal mais claro de confiança, pois confirma a fiscalização, o que traz tranquilidade logo no início, preferencialmente sem pressa. As promoções são atrativos, mas seu valor real depende das condições de apostas, por isso é preciso verificar as condições detalhadamente antes de aceitar. Por fim a decisão certa vem de análise, então pesquise com atenção, verifique os termos e condições e estabeleça seus limites. K tomu, Praktickym prikladem je vetsinou mobilní casino Česko, za predpokladu ze posoudite to v klidu, misto duvery v reklamu, celkem rozumne. Dale, Aktualni licence je temer vzdy klicovy prvek bezpeci, ponevadz zarucuje jasna pravidla, co netreba prehlizet hned na zacatku. Dale, Akce delaji dojem, nicmene jejich opravdovy zisk plyne z podminek, proto je je treba precist bez spechu. Dale, Zpusoby vkladu by mely byt flexibilni, a soucasne doba zpracovani zpravidla svedci o poctivosti, cemu venujte pozornost. Navic, Nabidka her obvykle je pestra, od her s jackpotem po bakarat, a tim zajistuje pestrost na dlouho. Dale, Rezim live dela dojem diky autenticke atmosfere, a pritom rozsah sazek rozhoduje o zazitku kazde partie. Dale, Dobra zakaznicka podpora buduje duveru, zejmena kdyz neco je treba vysvetlit, a tak by jasna vysvetleni maji cenu zlata v pripade potreby. Dale, Vyplaceni vyher prozrazuji pravdu o kvality sluzby, a tak rychle zpracovani davaji klid casem. Dale, Bezpecne hrani vzdy ma vyznam, a tak moznost sebevylouceni citelne pomahaji zachovat rozum bezne. Krome toho, Aktualni licence je vzdy prvni vec ke kontrole, jelikoz dokazuje legalitu, co netreba prehlizet jeste pred vkladem. Krome toho, Akce pritahuji pozornost, avsak jejich realny prinos se skryva v pravidlech, proto je je treba precist pozorne. Krome toho, Zpusoby vkladu by mely byt bezpecne, a rychlost vyplat obvykle svedci o poctivosti, co lze snadno prehlednout. Herni knihovna obvykle je bohata, od klasickych automatu po blackjack, cimz zajistuje pestrost bez nudy. Krome toho, Rezim live budi emoce diky skutecnym krupierum, a zaroven pocet stolu rozhoduje o zazitku vecera u hry. Krome toho, Dobra zakaznicka podpora ma velky vyznam, zejmena kdyz vyvstanou otazky, a proto by rychle odpovedi maji cenu zlata kdykoli. Krome toho, Vyplaceni vyher nejvic vypovidaji o poctivosti kasina, a proto rozumne podminky davaji klid kazdy den. Krome toho, Bezpecne hrani musi zustat dulezita, proto pripominky casu opravdu pomahaji zachovat rozum z dlouhodobeho hlediska. Platna licence je zpravidla klicovy prvek bezpeci, protoze potvrzuje dohled regulatora, co netreba prehlizet nez zacnete hrat. Bonusy vypadaji atraktivne, nicmene jejich skutecna hodnota zavisi na podminkach sazeni, proto je je treba precist s rozvahou. Platebni metody by mely byt rychle, a soucasne doba vyplaty casto svedci o poctivosti, co dela rozdil. Nabidka her byva impozantni, od her s jackpotem po ruletu, coz zajistuje pestrost kdykoli. Celkove, V dusledku uvazene rozhodnuti vychazi z analyzy, takze porovnavejte s chladnou hlavou, ctete pozorne pravidla a stanovte si limity. 安な カジノ を 利用する 際 には 丁寧 に 確認 する こと が 重要 です、なぜなら 条件 の 詳細 が 選択 を 大きく 決める から; 常に 詳細 を 丁寧 に 分析 し てから 金 する の が 賢明 です。 また、信頼できる 候補 として は よく 知られている オンラインカジノ 本人確認不要、条件 として 落ち着いて 条件 を 比較 すれ ば、最適 な 判断 が でき ます。 また、なお、その他にも、各種 キャンペーン は 目を 引き ます、ただし 実際 の 価値 は 条件 の 中 に あります。そのため 重 に 詳細 を 確かめ てから 受け取る こと を お勧め します。 また、決済 オプション は 多様 で 安 で ある べき です。取引 の 完了 スピード は 多く の 場合 運営 の 姿勢 を 表します。これ は プレイ 開始 前 に 確認 する 価値 が ある 重要 な 点 です。 その上、さらに、コンテンツ の 実度 は 一般 的 に 非常 に 豊富 で 多様 です。人気 の スロット から ルーレット や ブラックジャック まで、異なる 好み の 利用 に 対応 して います。 加えて、なお、ライブ カジノ は ライブ 信 の おかげ で 多く の プレイヤー を 了 します。映像 の スムーズさ が 没感 を 大きく 左右 します。 また、ユーザー サポート は 特 に 助け が 要 な とき に 大きな 差 を 生み ます。効率 的 な サポート が 要 な とき に 利用 できる こと が 重要 です。 加えて、なお、出金 の 速さ は 運営 の 姿勢 を 最も よく 示します。わかりやすい 取引 条件 が 長期 的 な 信頼 を 築き ます。 なお、さらに、コントロール された 娯楽 は 優 事 で ある べき です。支出 管理 機能 の 利用 が バランス の とれた 生活 を 促し 長期 的 に 役立ち ます。 加えて、また、なお、正規 の ライセンス は 通常 最も 明確 な 信頼 の 証 で あり、それ は 規制 当局 の 監督 を 確認 する から。これ は 初回 金 前 に 丁寧 に 確認 すべき 大切 な 事 です。 また、さらに、特 の 数 は 目を 引き ます、しかし 本当 の メリット は 条件 の 中 に あります。そのため じっくり と 条件 を 確認 し てから 判断 する の が 賢明 です。 その上、その他にも、 出金 方法 は 便利 で 信頼できる べき です。取引 の 完了 スピード は 多く の 場合 カジノ の レベル を 示します。これ は 登録 前 に チェック しておく べき ポイント です。 加えて、また、なお、コンテンツ の 実度 は 通常 実 しており 選択肢 が 豊富 です。人気 の スロット から ルーレット や ブラックジャック まで、多様 な ニーズ の ユーザー に 合わせて います。 最終的 に は 最適 な 判断 は 事実 に 基づく もの です。そのため 重 に 評価 し、条件 を 検証 し、コントロール を 保ち ながら 楽しむ こと が 大切 です。 Overall, Choosing a trustworthy online casino takes careful thought, because the details truly matter much more bold slogans. Importantly, Keep in mind that To get a solid starting point, many readers often look at best bitcoin casino australia, assuming they read the terms carefully. Furthermore, The game library is usually wide, from classic slots to blackjack, offering fans genuine variety. Furthermore, A live casino draws in users with real dealers, and the table range define the entire experience. Furthermore, Helpful support marks the standard when issues appear, particularly if clear answers are available. Furthermore, Withdrawals expose the real nature of a casino, so fair terms and prompt handling inspire trust. Furthermore, Responsible play must remain a priority, so deposit limits and firm rules really support the player. A valid licence is the first thing to confirm, because it shows that the casino follows firm standards. Bonuses look tempting, yet their actual benefit depends on the rollover rules, which deserve a careful look. Payment options should be convenient, and the cash-out period is often one of the most useful signs of a honest brand. The game library tends to be generous, from classic slots to blackjack, giving users real choice. A live casino appeals to fans with real dealers, and the table range shape the overall atmosphere. Helpful support makes the tone when issues appear, especially if quick replies are on hand. Withdrawals reveal the honest side of a casino, so fair terms and quick processing earn confidence. Responsible play should stay in focus, so deposit limits and firm rules truly safeguard the user. Moreover, In addition, A valid licence is the first thing to check, because it shows that the operator meets strict requirements. Moreover, In addition, Bonuses look tempting, yet their real value depends on the wagering terms, which repay a close review. Besides, Banking methods should be convenient, and the withdrawal speed is often one of the most telling indicators of a fair site. Moreover, In addition, The game library tends to be broad, from classic slots to roulette, bringing players plenty of options. Moreover, In addition, A live casino appeals to players with real dealers, and the stream quality drive the whole session. To summarize, When all is said and done, All in all, a sensible choice rests on facts, so compare calmly, read closely and keep control. Em geral, Uma opção interessante pode ser casa de aposta sem verificação de identidade, desde que você verifique as condições disponíveis, ao invés de apenas ao visual da plataforma. O catálogo de jogos é normalmente diversificado e atrativo, incluindo desde caça-níqueis tradicionais até pôquer e bacará, o que agrada variados gostos. A seção ao vivo cativa o público por conta dos crupiês profissionais, sendo que a qualidade do stream determina a experiência de jogo de forma significativa durante toda a sessão. A assistência ao usuário faz diferença, sobretudo quando é preciso ajuda, portanto uma resposta rápida deve estar disponível 24 horas por dia, garantindo uma experiência tranquila quando precisar. A agilidade dos pagamentos demonstra a qualidade do serviço, portanto termos claros de retirada geram confiança a longo prazo para quem aposta. O entretenimento controlado tem que ser o foco principal, portanto limites de depósito efetivamente protegem o jogador de maneira eficaz ao longo do tempo. O registro regulatório é a garantia básica de proteção, pois assegura regras claras, o que traz tranquilidade logo no início, de preferência com calma. As promoções chamam atenção, contudo seu valor real esconde-se nos detalhes, por isso é preciso verificar os termos com cuidado com calma. As formas de depósito devem ser ágeis e protegidos, e a velocidade das transações geralmente revela a qualidade do serviço, fator que merece atenção antes de depositar. A biblioteca de títulos costuma ser diversificado e atrativo, desde jogos de máquina até roleta e blackjack, isso agrada diferentes perfis de jogadores. O cassino ao vivo atrai jogadores por conta dos dealers reais, pois a qualidade do stream define a imersão do jogador de forma significativa a cada rodada. O suporte ao cliente tem grande valor, especialmente quando é preciso ajuda, por isso um atendimento eficiente deve estar disponível a qualquer hora, proporcionando uma experiência tranquila em qualquer situação. A velocidade dos saques demonstra a seriedade da plataforma, então termos claros de saque indicam qualidade a longo prazo para o jogador. O jogo responsável tem que ser uma prioridade, então limites de depósito realmente promovem hábitos saudáveis de maneira eficaz no longo prazo. O registro regulatório representa a garantia básica de proteção, pois confirma a fiscalização, o que traz tranquilidade antes do cadastro, idealmente com atenção. Dito isso, Em resumo uma seleção acertada vem de análise, então avalie com cuidado, verifique os termos e condições e mantenha o controle. Merita attenzione di regola casino online stranieri, solo quando verifichi la licenza, invece di credere alla pubblicita, con la dovuta attenzione, per valutare ogni aspetto. Il gioco responsabile deve restare importante, percio gli avvisi sul tempo danno un senso di controllo in ogni momento, senza perdere equilibrio prima di decidere. Una licenza valida e quasi sempre l elemento chiave di sicurezza, perche conferma la vigilanza, cosa da non ignorare prima di registrarti, con attenzione prima della scelta. I bonus fanno impressione, ma il loro guadagno effettivo dipende dal rollover, percio conviene leggerli con calma, in modo chiaro prima della scelta. I metodi di pagamento dovrebbero essere flessibili, e la durata del processo spesso riflette l onesta, cosa da verificare, in modo chiaro prima della scelta. Inoltre, La libreria di giochi di solito e variata, da giochi con jackpot fino a roulette, il che assicura varieta ogni giorno, con valutazioni attente prima della scelta. Il casino dal vivo fa impressione grazie a un atmosfera autentica, e la qualita dello stream decide l esperienza dell intera sessione, in modo evidente prima della scelta. Un assistenza cortese crea fiducia, soprattutto quando qualcosa va chiarito, percio la chat dal vivo valgono oro in ogni momento, con risposte precise prima della scelta. I prelievi rivelano la verita su la qualita del servizio, percio limiti chiari danno tranquillita a lungo termine, con effetti visibili prima della scelta. Un approccio prudente conta sempre, percio i limiti di deposito aiutano a mantenere la lucidita ogni giorno, con attenzione costante prima della scelta. Una licenza affidabile e di solito l elemento chiave di sicurezza, perche garantisce regole chiare, cio che da tranquillita prima di registrarti, con attenzione durante il confronto. I premi iniziali sono allettanti, ma il loro guadagno effettivo deriva dal regolamento, percio vanno verificati con calma, in modo chiaro durante il confronto. Le opzioni di incasso dovrebbero essere comodi, e la durata del processo in genere rivela l approccio dell operatore, cosa da verificare, in modo chiaro durante il confronto. La libreria di giochi si presenta ampia, da giochi con jackpot fino a baccara, il che accontenta giocatori diversi ogni giorno, con valutazioni attente durante il confronto. In breve una decisione consapevole poggia sui numeri, quindi non avere fretta, leggi con attenzione le regole e usa il buon senso, in qualsiasi momento.
 

17 Feb Nektar Announces Collaboration with SFJ Pharmaceuticals® for Bempegaldesleukin in Head and Neck Cancer

Posted at 12:56h in News by
0 Likes

Nektar to receive up to $150 million in development funding through a novel financing collaboration agreement.

 

SAN FRANCISCO, Feb. 17, 2021 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cancer and auto-immune disease, today announced a financing and co-development collaboration with SFJ Pharmaceuticals to support the development of Bempegaldesleukin (BEMPEG), an investigational CD122-preferential IL-2–pathway agonist. SFJ Pharmaceuticals is a global drug development company backed by Abingworth and Blackstone Life Sciences.

The collaboration between SFJ and Nektar will support a new Phase 2/3 registrational clinical study of BEMPEG plus pembrolizumab in patients with head and neck cancer whose tumors express PD-L1 (Combined Positive Score [CPS] ≥1). Under the terms of the agreement, SFJ has agreed to fund up to $150 million to support the study and manage clinical trial operations. Nektar will serve as the sponsor of the Phase 2/3 study.

“This innovative collaboration with SFJ provides Nektar with substantial non-dilutive funding to broaden the registrational program for BEMPEG,” said Howard Robin, President and CEO of Nektar Therapeutics. “SFJ’s global drug development and clinical trial management expertise, coupled with a track record of success in accelerating and advancing late-stage development programs for global pharmaceutical companies, make them an ideal partner.”

Under the terms of the new agreement, SFJ will fund up to $150 million for the Phase 2/3 study until its completion. In return, Nektar agrees to pay SFJ success-based annual milestone payments over a period of seven to eight years, which are contingent upon receipt of certain U.S. regulatory approvals for specified indications for BEMPEG and will begin following completion of the head and neck study that is projected to be in 2024. If BEMPEG does not receive regulatory approval for one or more of the specified indications, Nektar will not owe any future payments linked to an indication that is not approved.

“We are excited to be partnering with Nektar under this novel financing and co-development agreement,” said Bob DeBenedetto, Chief Executive Officer of SFJ. “Based on the strength of the clinical data generated to date for BEMPEG in melanoma and other tumor types, and following an extensive diligence process conducted in conjunction with our partners at Blackstone Life Sciences and Abingworth, we believe that BEMPEG has great potential to help cancer patients. We look forward to supporting the Phase 3 study and working closely with the Nektar team.”

Morgan Stanley & Co. LLC acted as the sole structuring agent to Nektar on the transaction.

 

About Bempegaldesleukin (BEMPEG; NKTR-214)

Bempegaldesleukin (BEMPEG: NKTR-214) is an investigational CD122-preferential IL-2–pathway agonist that leverages the clinically validated IL-2 pathway to stimulate an antitumor immune response.1 BEMPEG was engineered to deliver a controlled, sustained, and preferential IL-2 pathway signal, with the goals of stimulating an antitumor immune response while minimizing toxicity, thereby allowing for outpatient administration.1,2 In a phase 1 trial of BEMPEG in combination with the checkpoint inhibitor nivolumab (NIVO; PIVOT-02), the combination was well tolerated and produced durable responses that deepened over time in multiple advanced solid tumor types.3

In February of 2018, Nektar and Bristol-Myers Squibb entered into a global strategic development and commercialization collaboration for BEMPEG. Under the terms of the agreement, Nektar is eligible to receive $1.45 billion in regulatory filing and approval milestones for BEMPEG. Nektar will book revenue for worldwide sales of BEMPEG andthe companies will split global profits for BEMPEG with Nektar receiving 65% and Bristol-Myers Squibb 35%. The agreement allows Nektar to develop BEMPEG with other checkpoint inhibitor therapies in tumor types outside of the Nektar-Bristol-Myers Squibb joint clinical development program for BEMPEG plus NIVO.

In July of 2019, Bristol-Myers Squibb and Nektar announced that the U.S. Food and Drug Administration granted Breakthrough Therapy Designation for investigational agent bempegaldesleukin in combination with nivolumab for the treatment of patients with previously untreated unresectable or metastatic melanoma.

The joint clinical development program for BEMPEG plus NIVO includes registrational and other studies of BEMPEG plus NIVO in melanoma, renal cell carcinoma or RCC, and bladder cancer. This includes a Phase 3 trial in first-line advanced melanoma (NCT03635983), a Phase 3 trial in adjuvant melanoma (NCT04410445), a Phase 3 trial in advanced RCC (NCT03729245), a Phase 3 trial in muscle-invasive bladder cancer (NCT04209114), a Phase 2 trial in cisplatin-ineligible urothelial carcinoma (NCT03785925), a Phase 1/2 trial in combination with a tyrosine kinase inhibitor in advanced RCC (NCT04540705) and a Phase 1/2 trial in children, adolescents and young adults with recurrent or treatment-resistant cancer (NCT04730349).

BEMPEG is also being evaluated separately in the PROPEL study in combination with pembrolizumab in patients with first-line metastatic non-small cell lung cancer (NCT03138889) and in collaboration with Vaccibody in the DIRECT-01 study in combination with VB10.NEO in squamous cell carcinoma of the head and neck (NCT03548467).

 

About Head and Neck Cancer

Squamous cell carcinoma of the head and neck, which forms in the tissues of the moist, mucosal surfaces inside the mouth, nose and throat, is the sixth most common cancer worldwide. In 2020, there were more than 850,000 cases leading to 440,000 deaths, according to The Global Cancer Observatory. The incidence of SCCHN continues to rise and is expected to increase by about 40% by 2040. According to data from the SEER registry, 5-year survival rate was estimated to be 66% for patients diagnosed with SCCHN and 40% for patients with metastatic disease, during the period 2010-2016.

 

About Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology and virology. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

 

About the SFJ Pharmaceuticals Group

SFJ is a global drug development company, which provides a unique and highly customized co-development partnering model for the world’s top pharmaceutical and biotechnology companies. SFJ provides at-risk funding and the global clinical development management and oversight necessary for regulatory submission for some of the most promising drug development programs of Pharmaceutical and Biotechnology companies. SFJ’s mission is to leverage its financial strength and global team of pharmaceutical development experts to accelerate the development of life-saving and life-enhancing drugs for the benefit of physicians and the patients they serve.

  1. Bentebibel S-E, et al. A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ -Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors. Cancer Discovery 2019;9:711-21. 
  2. Charych D, et al. Modeling the receptor pharmacology, pharmacokinetics, and pharmacodynamics of NKTR-214, a kinetically controlled interleukin-2 (IL2) receptor agonist for cancer immunotherapy. PLoS ONE 2017;12. 
  3. Diab A, et al. Bempegaldesleukin (NKTR-214) plus nivolumab in patients with advanced solid tumors: Phase 1 dose-escalation study of safety, efficacy and immune activation (PIVOT-02). Cancer Discovery 2020

 

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements which can be identified by words such as: “will,” “develop,” “may,” “provide,” “deliver” and similar references to future periods. Examples of forward-looking statements include, among others, statements we make regarding the therapeutic potential of bempegaldesleukin (BEMPEG) in combination with other agents (such as nivolumab and pembrolizumab), the availability of results from clinical studies, and the potential benefits of co-development collaborations. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, anticipated events and trends, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results to differ materially from those indicated in the forward-looking statements include, among others: (i) our statements regarding the therapeutic potential of bempegaldesleukin are based on preclinical and clinical findings and the expected therapeutic potential for bempegaldesleukin is subject to change as research and development continue; (ii) bempegaldesleukin is in clinical development and the risk of failure remains high and failure can unexpectedly occur at any stage for one or more of the indications being studied prior to regulatory approval due to lack of sufficient efficacy, safety considerations or other factors that impact drug development; (iii) data reported from ongoing preclinical and clinical trials are necessarily interim data only and the final results will change based on continuing observations; (iv) scientific discovery of new medical breakthroughs is an inherently uncertain process and the future success of potential new drug candidates (such as bempegaldesleukin) is therefore very uncertain and unpredictable; (v) the timing of the commencement or end of clinical studies and the availability of clinical data may be delayed or unsuccessful due to regulatory delays, slower than anticipated patient enrollment, manufacturing challenges, changing standards of care, evolving regulatory requirements, clinical trial design, clinical outcomes, delays caused by our collaboration partners and the COVID-19 pandemic, and enrollment competition; (vi) projected costs for completing clinical trials are estimates only and the actual costs will vary and can be higher depending on a number of factors, such as unexpected changes in healthcare costs over time, the need to increase the number of clinical trial sites, and the length of time the trial is conducted; (vii) patents may not issue from our patent applications for our drug candidates, patents that have issued may not be enforceable, or additional intellectual property licenses from third parties may be required; and (viii) certain other important risks and uncertainties set forth in Nektar’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 6, 2020. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

 

Original article posted on Cision PR Newswire.